Tobii Signs Integration Customer in Health Care Sector

Tobii Tech
Press release

Tobii has signed a collaboration and supply agreement with RightEye LLC, a US company that offers patient care and vision performance solutions using eye tracking. Studying eye movements reveals indications of conditions such as concussion, autism and Parkinson’s disease.

RightEye is a health technology company focused on the development and delivery of eye-tracking tests and therapies. The company’s vision tests and vision training games aid in the detection and treatment of concussion, brain damage and other conditions affecting learning and living that may be revealed by observing attention and eye movements. Tobii provides eye-tracking systems for RightEye, which develops the complete solution using its proprietary cloud-based software.

“We are seeing growing demand for eye tracking in diagnostics and other medical applications where the technology offers clear benefits,” said Henrik Eskilsson, CEO of Tobii. “RightEye has produced innovative and easy-to-use solutions for identifying both temporary injuries and other conditions that affect cognitive abilities, physical performance and quality of life. This represents an exciting market with good potential for development.”

Tobii has a strong foothold in eye-tracking solutions for research as well as in eye-controlled assistive communication solutions. With leading eye-tracking technology for integration, Tobii also enables companies in a broad spectrum of industries to include eye tracking in their solutions. RightEye is joining current integration customers, including computer manufacturers such as Dell and Acer, smartphone manufacturer Huawei, and companies in the medical technology industry. RightEye’s operations are based in the U.S., and customers include opticians, customers in the hospital care sector and professional sports teams. Tobii’s deliveries will be paced by RightEye’s sales, beginning 2018.

“By partnering with Tobii, we’re able to fully leverage the power of their eye-tracking technology with our cloud-based platform to bring entirely new tools for tests and therapies to doctors, patients and athletes,” said Adam Gross, RightEye CEO and co-founder. “We are incredibly excited because we see the positive difference we can make in people’s lives, and we are just getting started.”

RightEye will showcase the new solution at CES in Las Vegas Jan. 9-12, 2018, in booth #43037 in the Health & Wellness Marketplace in Sands Halls A-D.

Contacts

Contact

Cecilia Lago Albright, PR & Communications Manager, Tobii Pro, Phone: +46 707 43 13 45, email: cecilia.albright@tobii.com

Sara Hyléen, Director of Corporate Communications and Investor Relations, Tobii AB, Phone: +46 709 16 16 41, email: sara.hyleen@tobii.com

About Tobii

Tobii is the global leader in eye tracking. Our vision is a world where all technology works in harmony with natural human behavior. Tobii operates through three business units: Tobii Dynavox makes specially designed computers that are controlled by eye movement or touch screens for use by people with special needs due to spinal cord injuries, CP, ALS or other medical conditions. Tobii Pro develops and sells eye-tracking equipment and services used today by more than 3,000 companies and 2,000 research institutions, including all of the world’s 50 highest ranked universities. Tobii Tech further develops Tobii’s technology for new volume markets, such as computer games, personal computers, virtual reality and smartphones. Tobii is headquartered in Sweden and is listed on Nasdaq Stockholm (TOBII). The group has over 900 employees. For more information, please visit www.tobii.com